< Back to companies

Alpha Intelligence Manifold Inc. focuses on providing affordable smart precision care aimed at serving the aging society. The company strives to achieve 10x efficiency at 1/10th the cost of existing diagnostic processes, thereby supporting dignified aging. They address current pain points in healthcare related to osteoporosis and osteoarthritis by offering AI-assisted diagnostic systems such as DeepXray™ Coxa and DeepXray™ Genu, which utilize X-ray precision diagnostics and automated monitoring. Their platform, DeepPACS, also enhances workflow efficiency through zero-click instant AI report generation. The company aims to improve patient journeys and outcomes by providing innovative, evidence-based early diagnostic tools and services.

Share
Shareable draft
Get Involved in AIM (采風智匯)

Company Info

Founded
2020
Website
www.aimfolds.com/

Categories

DiagnosticsHealthy Aging & LongevityQuality ImprovementScreening & Early Detection

Disease Areas

Technologies

DiagnosticsHealth TechnologyDecision Support
Only accessible to MedStartr community members. Join now

What do you think of AIM (采風智匯)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in AIM (采風智匯)
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free